The company offers year-round educational services on the conditions, using this month in particular to guide patients to ...

Korean investigators reported that faricimab (Vabysmo, Roche/Genentech) in a real-world setting works well for patients with neovascular age-related macular degeneration (nAMD) refractory to other ...

Ashkan Abbey, MD, shares insights from the one-year data for the phase 2 DAVIO2 trial and the impact of tyrosine kinase inhibitors on reducing treatment burden. Basically, we were looking at the ...

Panelists discuss how the potential availability of tyrosine kinase inhibitors (TKIs) could diminish some advantages of the PDS system, as oral medications would provide an alternative approach to ...

EYLEA’s unique MoA: What is the rationale for the higher molar dose?

4D Molecular Therapeutics announced it will present the initial interim 52-week data from the Phase 2b Population Extension cohort of the PRISM clinical trial. The trial is evaluating 4D-150 in a ...

A large study that retrospectively analyzed the visual outcomes and rate of development of neovascular age-related macular degeneration (nAMD) in eyes with geographic atrophy (GA) found that GA can ...

The Sentinel Camera aims to address critical gaps in retinal disease screening by offering a portable device that captures high-quality images that require no dilation of the eye. AI Optics, an ...

A new study 1 from Turkey reported that during the acute phase of the COVID-19 infection, the retinal vascularity and perfusion of the retina decreases and the foveal avascular zone (FAZ) expands. The ...

Panelists discuss how ideal candidates for aflibercept 8 mg include patients with stable disease on current anti-VEGF therapy who seek reduced treatment burden, newly diagnosed patients, and those ...

Panelists discuss how faricimab’s bispecific antibody design uniquely targets both VEGF-A and Ang-2 pathways, addressing the complementary role of Ang-2 in vascular destabilization and inflammation in ...